Related Experiment Video
Updated: Jul 8, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Ultrastructural definition of apoptosis in heart failure
Eloisa Arbustini1, Agnese Brega, Jagat Narula
1Centro Malattie Genetiche Cardiovascolari, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy. e.arbustini@smatteo.pv.it
Insights
Cardiac myocytes undergo apoptosis, oncosis, and autophagy. These cell death pathways, particularly apoptosis and autophagy, are observed in failing human hearts, suggesting potential shared therapeutic targets for preserving myocyte integrity.
Area of Science:
- Cardiovascular Biology
- Cellular Pathology
Background:
- Cardiac myocytes exhibit multiple cell death pathways, including apoptosis, oncosis, and autophagy.
- Understanding these mechanisms is crucial for addressing heart failure.
- Apoptosis involves nuclear fragmentation and apoptotic bodies, with clearance by macrophages without inflammation.
Purpose of the Study:
- To describe the morphological characteristics of cardiac myocyte death.
- To investigate the prevalence and significance of apoptosis, oncosis, and autophagy in failing human hearts.
- To explore potential shared therapeutic strategies for preserving myocyte integrity.
Main Methods:
- Light and electron microscopy to visualize morphological changes.
- Immunoelectron microscopy for detailed analysis of apoptotic markers (cytochrome c, TUNEL, annexin V).
- Observation of myocyte death features in human decompensated hearts.
Main Results:
- Apoptosis is characterized by nuclear fragmentation and apoptotic bodies, cleared without inflammation.
- Oncosis presents distinct morphological features and can coexist with apoptosis, especially in ischemic conditions.
- Autophagy, a defense mechanism, can lead to necrosis if lysosomal removal is impaired.
- While late-stage apoptosis and autophagy are rare in failing hearts, early apoptotic and autophagic changes are present in viable myocytes across various etiologies.
Conclusions:
- Morphological features of apoptosis, oncosis, and autophagy can coexist in cardiac myocytes.
- Early signs of apoptosis and autophagy are detectable in viable myocytes of failing human hearts, irrespective of etiology.
- The shared pathways of myocyte death suggest that therapeutic strategies targeting these mechanisms could preserve myocyte integrity in heart failure.
Abstract:
Cardiac myocytes die through apoptosis, oncosis, and autophagy. Apoptosis affects single cells and is morphologically characterized by nuclear fragmentation with generation of apoptotic bodies that can be seen either within dying cells or free in the interstitial spaces. Dead myocytes are removed by macrophages through phagocytosis without triggering inflammation. The circulating markers of myocyte necrosis are not increased by apoptosis. The morphologic changes of the induction and early execution phases are seen at electron microscopy while late fragmentation is visible on both light and electron microscopy. Immunoelectron microscopy provides combined functional and structural information showing cytochrome c immuno-labelling release from mitochondria, TUNEL labelling of apoptotic nuclei, annexin V translocation in the outer plasma cell layer. Oncosis is characterized by specific morphologic features that may coexist with apoptosis, especially in ischemic myocardium. Autophagy is a defense process that is associated with significant myocardial damage and necrosis when removal of the lysosomal content is impaired. Morphological features of apoptosis, oncosis, and autophagocytosis may coexist at the same time. Although dead myocytes showing characteristics of autophagy and apoptosis are rarely observed in human decompensated hearts, autophagic vacuoles, and early apoptotic changes may be seen more often in morphologically viable myocytes. Such features may occur in failing hearts of both ischemic and non-ischemic etiology. The shared mode of cardiac myocyte death in failing human hearts of different etiologies suggests that preservation of myocyte integrity may be possible by similar therapeutic strategies.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Apoptosis
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
The Intrinsic Apoptotic Pathway
